Updated: March 27, 2026
Bacitracin Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Bacitracin still in shortage in 2026? Get the latest update on availability, costs, alternatives, and when supply is expected to return.
Bacitracin Shortage in 2026: Here's What's Happening
If you've been unable to find Bacitracin at your pharmacy recently, you're dealing with the effects of an ongoing drug shortage that has impacted patients across the country. In this article, we'll give you the latest update on the Bacitracin shortage, explain what's causing it, and share practical steps you can take.
Is Bacitracin Still in Shortage?
As of early 2026, yes — Bacitracin is still in shortage, specifically the prescription ophthalmic ointment (the eye form).
Here's the current situation:
- Bacitracin ophthalmic ointment (Rx) — In active shortage. Padagis US, the primary manufacturer, temporarily discontinued the 3.5-gram tube in early 2025. The estimated resupply date is October 2026, according to the American Society of Health-System Pharmacists (ASHP).
- Bacitracin topical ointment (OTC) — Generally available. Multiple manufacturers produce this form, so while spot shortages may occur, it's usually findable at pharmacies, drugstores, and online retailers.
- Bacitracin for injection — Permanently withdrawn from the U.S. market. In 2020, the FDA requested all manufacturers voluntarily pull this product due to serious safety concerns including kidney damage and anaphylactic reactions.
Why Is Bacitracin Hard to Find?
The shortage comes down to a few key factors:
Manufacturer Discontinuation
Padagis US was the primary supplier of Bacitracin ophthalmic ointment in the United States. When they discontinued production — even temporarily — it created a gap that no other manufacturer has been able to fill. This is a common pattern in drug shortages: when a market has only one or two manufacturers, any disruption has an outsized impact.
Limited Competition
Unlike common oral medications that have dozens of generic manufacturers, Bacitracin ophthalmic ointment is made by very few companies. The economics of sterile ophthalmic manufacturing are challenging, which discourages new competitors from entering the market.
Supply Chain Challenges
Raw material sourcing, quality control requirements, and distribution logistics all play a role. Sterile ophthalmic products face particularly strict manufacturing standards, making it harder to quickly ramp up production.
For a deeper dive into the causes, read our article on why Bacitracin is so hard to find in 2026.
How Much Does Bacitracin Cost in 2026?
Costs vary depending on which form you need:
- OTC topical ointment: $2.52 to $13.44 at retail. Discount cards from GoodRx or SingleCare can bring the price as low as $2.52.
- Prescription ophthalmic ointment: $10.20 to $46.39, depending on the pharmacy. With a SingleCare coupon, you may pay around $10.20 for a 14g tube.
If you have insurance, the ophthalmic form is typically covered as a Tier 1 generic with a low copay. The OTC form is generally not covered by insurance since it doesn't require a prescription. For more on pricing, see our guide to saving money on Bacitracin.
Are There New Options or Alternatives?
While no new Bacitracin products have entered the market, you have several alternatives:
For Minor Wound Care (OTC)
- Polysporin — Double antibiotic ointment containing Bacitracin + Polymyxin B ($5-$12)
- Neosporin — Triple antibiotic ointment containing Bacitracin + Neomycin + Polymyxin B ($5-$15)
- Petroleum jelly (Aquaphor) — Studies show it's equally effective for clean minor wounds ($3-$10)
For Eye Infections (Rx)
- Erythromycin ophthalmic ointment — The most commonly prescribed alternative
- Tobramycin ophthalmic — Available as drops or ointment
- Ciprofloxacin ophthalmic drops — A fluoroquinolone option
- Polytrim (Polymyxin B/Trimethoprim) drops — Another widely used combination
For a full comparison, read alternatives to Bacitracin.
How to Find Bacitracin in Stock Right Now
Even during a shortage, some pharmacies still have Bacitracin available. Here's how to find it:
- Use Medfinder — Check real-time pharmacy stock near your zip code
- Try independent pharmacies — They often have supplies that chain pharmacies don't
- Ask about compounding — Compounding pharmacies may be able to prepare Bacitracin ophthalmic ointment
- Check online retailers — For the OTC form, Amazon and Walmart.com often have stock
- Ask your pharmacist to order it — Your pharmacy may be able to special-order it from their wholesaler
For more detailed strategies, check out how to find Bacitracin in stock near you.
What About Telehealth?
If you need a prescription for Bacitracin ophthalmic ointment or an alternative, many doctors now offer telehealth appointments. A provider can evaluate your symptoms via video call and send a prescription to the pharmacy of your choice. This is especially helpful when you've already found a pharmacy with stock and just need a prescription directed there. Learn more about finding a prescriber near you.
Final Thoughts
The Bacitracin shortage — particularly for the ophthalmic form — is expected to continue through much of 2026, with resupply estimated around October. The OTC topical form is more widely available but can be harder to find in some areas.
The best thing you can do is stay informed, use tools like Medfinder to check stock, and talk to your doctor about alternatives if you can't find what you need. This shortage will end, but in the meantime, you have real options.
Want to understand what Bacitracin does and how it works? Read our articles on Bacitracin uses and dosage and how Bacitracin works.
Frequently Asked Questions
Padagis US, the primary manufacturer of Bacitracin ophthalmic ointment, estimates resupply around October 2026. The OTC topical form is generally available from multiple manufacturers. The injectable form has been permanently withdrawn from the market and will not return.
No, there is no recall. The current issue is a manufacturer-initiated shortage, not a safety recall. Padagis US temporarily discontinued production of Bacitracin ophthalmic ointment due to manufacturing issues, not product safety concerns. The Bacitracin injection withdrawal in 2020 was separate and permanent.
It depends on the pharmacy. Some pharmacies may still have limited stock of the ophthalmic form. Use Medfinder to check availability near you. If no pharmacy has it, ask your doctor about alternative ophthalmic antibiotics like Erythromycin ointment or Tobramycin drops.
The current shortage primarily affects Bacitracin ophthalmic ointment (the eye form). Neosporin and Polysporin — which are OTC combination products that contain Bacitracin — are generally still available. However, if Bacitracin supply issues worsen, it could potentially impact these products in the future.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
32,326 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)



